OmniAb (OABI) Assets (2021 - 2026)
OmniAb (OABI) reported Assets of $293.6 million for Q1 2026, down 4.09% year-over-year from $306.2 million in Q1 2025, and down 2.41% on a QoQ basis from $300.9 million in Q4 2025.
OmniAb (OABI) has 6 years of Assets data on file, last reported at $293.6 million in Q1 2026.
- Quarterly Assets fell 4.09% year-over-year to $293.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $293.6 million (down 4.09% YoY) and the FY2025 annual result came in at $300.9 million, down 7.57% from the prior year.
- Assets declined to $293.6 million in Q1 2026 per OABI's latest filing, from $300.9 million in the prior quarter.
- Across five years, Assets topped out at $421.2 million in Q4 2022 and bottomed at $236.8 million in Q2 2022.
- The 5-year median for Assets is $325.6 million (2024), against an average of $327.7 million.
- The widest annual swing landed in 2022, when Assets jumped 37283.13%; it then declined 16.77% in 2024.
- Tracing OABI's Assets over 5 years: stood at $421.2 million in 2022, then declined by 10.92% to $375.2 million in 2023, then slipped by 13.24% to $325.6 million in 2024, then slipped by 7.57% to $300.9 million in 2025, then retreated by 2.41% to $293.6 million in 2026.
- Per Business Quant, the three latest OABI Assets figures stand at $293.6 million (Q1 2026), $300.9 million (Q4 2025), and $309.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 14.93 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.37 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.73 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 78.88 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 33.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.48 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 23.64 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.87 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.13 Bn |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn | 293.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 293.65 Mn |
| Dec 31, 2025 | 300.91 Mn |
| Sep 30, 2025 | 309.69 Mn |
| Jun 30, 2025 | 295.67 Mn |
| Mar 31, 2025 | 306.18 Mn |
| Dec 31, 2024 | 325.56 Mn |
| Sep 30, 2024 | 331.55 Mn |
| Jun 30, 2024 | 337.26 Mn |
| Mar 31, 2024 | 352.56 Mn |
| Dec 31, 2023 | 375.23 Mn |
| Sep 30, 2023 | 391.71 Mn |
| Jun 30, 2023 | 405.24 Mn |
| Mar 31, 2023 | 413.04 Mn |
| Dec 31, 2022 | 421.21 Mn |
| Sep 30, 2022 | 237.61 Mn |
| Jun 30, 2022 | 236.79 Mn |
| Mar 31, 2022 | 236.90 Mn |
| Dec 31, 2021 | 304.47 Mn |
| Sep 30, 2021 | 236.99 Mn |
| Jun 30, 2021 | 633,415.00 |